March 2018 - Volume 113 - Issue 3 - Contributor Index

Alphabetical Search
Q

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Author:
Andriulli, A MD

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Author:
Arroyo, M MD

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Author:
Bale, Allen E
Author:
Bartolo, O MD

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Author:
Basili, S MD
Author:
Benitez, J M MD

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Author:
Ber, Y MD

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease

Lewis, James D; Scott, Frank I; Brensinger, Colleen M; More

American Journal of Gastroenterology. 113(3):405-417, March 2018.

Eosinophilic Esophagitis: Relationship of Subepithelial Eosinophilic Inflammation With Epithelial Histology, Endoscopy, Blood Eosinophils, and Symptoms

Schoepfer, Alain M; Simko, Audrey; Bussmann, Christian; More

American Journal of Gastroenterology. 113(3):348-357, March 2018.

Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era—Results from the Dutch Population-Based IBDSL Cohort

Jeuring, Steven F G; Biemans, Vince B C; van den Heuvel, Tim R A; More

American Journal of Gastroenterology. 113(3):384-395, March 2018.

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Eosinophilic Esophagitis: Relationship of Subepithelial Eosinophilic Inflammation With Epithelial Histology, Endoscopy, Blood Eosinophils, and Symptoms

Schoepfer, Alain M; Simko, Audrey; Bussmann, Christian; More

American Journal of Gastroenterology. 113(3):348-357, March 2018.

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease

Lewis, James D; Scott, Frank I; Brensinger, Colleen M; More

American Journal of Gastroenterology. 113(3):405-417, March 2018.

Eosinophilic Esophagitis: Relationship of Subepithelial Eosinophilic Inflammation With Epithelial Histology, Endoscopy, Blood Eosinophils, and Symptoms

Schoepfer, Alain M; Simko, Audrey; Bussmann, Christian; More

American Journal of Gastroenterology. 113(3):348-357, March 2018.

Eosinophilic Esophagitis: Relationship of Subepithelial Eosinophilic Inflammation With Epithelial Histology, Endoscopy, Blood Eosinophils, and Symptoms

Schoepfer, Alain M; Simko, Audrey; Bussmann, Christian; More

American Journal of Gastroenterology. 113(3):348-357, March 2018.

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Author:
Caprio, Sonia

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Author:
Chalasani, Naga

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease

Lewis, James D; Scott, Frank I; Brensinger, Colleen M; More

American Journal of Gastroenterology. 113(3):405-417, March 2018.

Author:
Corazza, G R MD

Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease

Lewis, James D; Scott, Frank I; Brensinger, Colleen M; More

American Journal of Gastroenterology. 113(3):405-417, March 2018.

Author:
D'Angelo, E MD

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Author:
Dellatte, S MD
Author:
Di Sessa, Anna

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Author:
Donday, M G MSc

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Author:
Dykas, Daniel J

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Author:
Garre, A MSc

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Author:
Gentile, A MD
Author:
Giorgio, V MD

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Eosinophilic Esophagitis: Relationship of Subepithelial Eosinophilic Inflammation With Epithelial Histology, Endoscopy, Blood Eosinophils, and Symptoms

Schoepfer, Alain M; Simko, Audrey; Bussmann, Christian; More

American Journal of Gastroenterology. 113(3):348-357, March 2018.

Author:
Gompertz, M MD

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Eosinophilic Esophagitis: Relationship of Subepithelial Eosinophilic Inflammation With Epithelial Histology, Endoscopy, Blood Eosinophils, and Symptoms

Schoepfer, Alain M; Simko, Audrey; Bussmann, Christian; More

American Journal of Gastroenterology. 113(3):348-357, March 2018.

Author:
Grimm, Ian MD
Author:
Guerra, I MD

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Author:
Hamada, Kenta

Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era—Results from the Dutch Population-Based IBDSL Cohort

Jeuring, Steven F G; Biemans, Vince B C; van den Heuvel, Tim R A; More

American Journal of Gastroenterology. 113(3):384-395, March 2018.

Author:
Hu, Jui-Ting MD

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Author:
Iade, B MD

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Author:
Indrio, F MD

Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era—Results from the Dutch Population-Based IBDSL Cohort

Jeuring, Steven F G; Biemans, Vince B C; van den Heuvel, Tim R A; More

American Journal of Gastroenterology. 113(3):384-395, March 2018.

Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era—Results from the Dutch Population-Based IBDSL Cohort

Jeuring, Steven F G; Biemans, Vince B C; van den Heuvel, Tim R A; More

American Journal of Gastroenterology. 113(3):384-395, March 2018.

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.

Author:
Kaufman, Adam
Author:
Laine, Loren MD
Author:
Lander, Jared

Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease

Lewis, James D; Scott, Frank I; Brensinger, Colleen M; More

American Journal of Gastroenterology. 113(3):405-417, March 2018.

Author:
Licata, A MD
Author:
Lissner, D MD

Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

Chaparro, M; Verreth, A; Lobaton, T; More

American Journal of Gastroenterology. 113(3):396-403, March 2018.